The views of Alzheimer disease patients and their study partners on proxy consent for clinical trial enrollment.
Karlawish JHT, Kim S, Knopman D, van Dyck CH, James BD, Marson D. American Journal of Geriatric Psychiatry . 16(3):240-247, 2008.

Ethics of sham surgery: Perspective of patients.
Frank S, Wilson R, Holloway RG, Zimmerman C, Peterson DR, Kieburtz K, Kim S. Movement Disorders . In Press, 2007.

Determining when impairment constitutes incapacity for informed consent in schizophrenia research.
Kim S, Appelbaum PS, Swan JG, Stroup S, McEvoy JP, Goff DC, Jeste DV, Lamberti JS, Leibovici A, Caine ED. British Journal of Psychiatry . 191:38-43, 2007.

Assessing and communicating risks and benefits of gene transfer clinical studies.
Kim S. Current Opinion in Molecular Therapeutics. 8:384-389, 2006.

The capacity to appoint a proxy and the possibility of concurrent proxy directives.
Kim S, Appelbaum PS. Behavioral Sciences and the Law . 24:469-478, 2006.

Do clinicians follow a risk-sensitive model of capacity determination? An experimental video survey.
Kim S, Caine ED, Swan JG, Appelbaum PS. Psychosomatics . 47:325-329, 2006.

How does news about suicidality and antidepressants affect patients being treated for depression?
Muroff JR, Kim S. Psychiatric Services . 57:723-724, 2006.

Volunteering for early phase gene transfer research in Parkinson's disease.
Kim S, Holloway RG, Frank S, Beck CA, Zimmerman C, Wilson R, Kieburtz K. Neurology. 66:1010-1015, 2006.

Competency for creation, use, and revocation of psychiatric advance directives.
Srebnik DS, Kim S. Journal of the American Academy of Psychiatry Law. 34:501-510, 2006.

Appointing a proxy for research consent after one develops dementia: The need for further study.
Kim S, Kieburtz K. Neurology. 66:1298-1299, 2006.

Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial.
Stroup S, Appelbaum PS, Swartz M, Patel M, Davis S, Jeste DV, Kim S, Keefe R, Manschreck T, McEvoy JP, Lieberman J. Schizophrenia Research . 80:1-8, 2005.

What do people at risk for Alzheimer's disease think about surrogate consent for research?
Kim S, Kim HM, McCallum C, Tariot PN. Neurology. 65:1395-1401, 2005.

Is psychiatric research stigmatized? An experimental survey of the public.
Muroff JR, Hoerauf SL, Kim S. Schizophrenia Bulletin. 32:129-136, 2005.

When does decisional impairment become decisional incompetence? Ethical and methodologial issues in capacity research in schizophrenia.
Kim S. Schizophrenia Bulletin. 32:92-97, 2005.

Science and ethics of sham surgery: A survey of Parkinson disease clinical researchers.
Kim S, Frank S, Holloway RG, Zimmerman C, Wilson R, Kieburtz K. Archives of Neurology . 62:1357-1360, 2005.

What is the risk of sham surgery in Parkinson's disease clinical trials? A review of published reports.
Frank S, Kieburtz K, Holloway RG, Kim S. Neurology. 65:1101-1103, 2005.

The ability of people with Alzheimer disease (AD) to make a decision about taking an AD treatment.
Karlawish JHT, Casarett DJ, James BD, Xie S, Kim S. Neurology. 64:1514-1519, 2005.

The dilemma of hidden ethical dilemmas.
Kim S. Academic Psychiatry. 28:168-169, 2004.

Evidence-based ethics in neurology and psychiatry research.
Kim S. NeuroRx. 1:372-377, 2004.

Proxy and surrogate consent in geriatric neuropsychiatric research: Update and recommendations.
Kim S, Appelbaum PS, Jeste DV, Olin J. American Journal of Psychiatry . 161:797-806, 2004.

Potential research participants' views regarding researcher and institutional financial conflicts of interest.
Kim S, Millard RW, Nisbet P, Cox C, Caine ED. Journal of Medical Ethics. 30:73-79, 2004.

Benefits and burdens of placebos in psychiatric research.
Kim S. Psychopharmacology . 171:13-18, 2003.

Burdens and benefits of placebos in antidepressant clinical trials: A decision and cost-effectiveness analysis.
Kim S, Holloway RG. American Journal of Psychiatry . 160:1272-1276, 2003.

The sham surgery debate and the moral complexity or risk-benefit analysis.
Kim S. American Journal of Bioethics. 3:66-68, 2003.

Ethics and politics of research involving subjects with impaired decision-making abilities.
Kim S, Karlawish JHT. Neurology. 61:1645-1646, 2003.

Utility and limits of the Mini Mental State Examination when evaluating consent capacity in Alzheimer's disease.
Kim S, Caine ED. Psychiatric Services . 53:1322-1324, 2002.

Ethical issues in including suicidal individuals in clinical research.
Fisher CB, Pearson JL, Kim S, Reynolds CF. IRB: Ethics & Human Research. 24:9-14, 2002.

Impaired decision-making ability in subjects with Alzheimer's disease and willingness to participate in research.
Kim S, Caine ED, Cox C. American Journal of Psychiatry . 157:797-802, 2002.

Current state of research on decision-making competence of cognitively impaired elderly.
Kim S, Karlawish JHT, Caine ED. American Journal of Geriatric Psychiatry . 10:151-165, 2002.

Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research.
Kim S, Caine ED, Currier GW, Leibovici A, Ryan JM. American Journal of Psychiatry . 158:712-717, 2001.